Tilray Brands, Inc. - Common Stock (TLRY)

Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.

Tuesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

A number of stocks jumped in the morning session after the release of a favorable Consumer Price Index (CPI) report, which showed inflation cooling more than anticipated. The July report from the Bureau of Labor Statistics indicated a year-over-year inflation rate of 2.7%, just below the 2.8% economists had forecast. This suggests that price pressures on consumers may be easing. Particularly beneficial for the sector was the news that the food index remained flat, with grocery prices even declining by 0.1% month-over-month. This development is seen as a positive for the profitability of food, beverage, and personal care companies, as lower input costs and increased consumer purchasing power could boost sales. 

Tilray rolls out 10mg hemp-derived THC drinks as Trump weighs cannabis reclassification, potentially easing federal barriers and widening U.S. access.

U.S. stock futures were swinging between gains and losses on Tuesday following Monday's decline. Futures of benchmark indices were mixed.

Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.

U.S. stocks closed lower on Monday, with the Dow Jones Industrial Average slipping 0.45% to 43,975.09

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 38.5% in the afternoon session after reports that President Donald Trump is considering reclassifying marijuana as a less dangerous drug, a move that could transform the cannabis industry's regulatory landscape. 

Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 4.9% in the afternoon session after the company announced the launch of its new Humble Seed Whole Wheat Protein Crackers, now available at Whole Foods Market. This move marked a notable expansion of the company's wellness product offerings into a major retail chain. The positive sentiment also followed other recent events. Earlier in the week, an analyst upgraded the stock to a "Buy" rating, and at the end of July, CEO Irwin D. Simon purchased 165,000 shares. This insider purchase signaled strong confidence in the company's direction.

Spoiler: The answer isn't pretty. In fact, it's worse than ugly.

The company posted an adjusted net profit in its latest reported quarter, but there wasn't much else producing a high for investors.

These stocks may seem like hot buys right now, but they come with significant risks.

Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago.

Tilray stock plunged yesterday, July 29, following a brutal fiscal Q4 earnings report that reinforced concerns about Tilray’s strategic direction and financial health spooking investors. Other LPs dropped in sympathy.

Tilray overpaid for acquisitions in 2021 -- and Tilray stock is paying for that mistake today.